Reduced progression of adriamycin nephropathy in spontaneously hypertensive rats treated by losartan | Zendy

Nevena MihailovicStanojevic | Zendy; Djurdjica Jovović | Zendy; Zoran Miloradović | Zendy; Jelica Grujić-Milanović | Zendy; Mirjana Jerkić | Zendy; Jasmina MarkovicLipkovski | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Reduced progression of adriamycin nephropathy in spontaneously hypertensive rats treated by losartan

Author(s) -

Nevena MihailovicStanojevic,

Djurdjica Jovović,

Zoran Miloradović,

Jelica Grujić-Milanović,

Mirjana Jerkić,

Jasmina MarkovicLipkovski

Publication year - 2008

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfn596

Subject(s) - losartan , medicine , hypertensive nephropathy , nephropathy , endocrinology , hypertensive disease , urology , angiotensin receptor , angiotensin ii , pharmacology , kidney , receptor , diabetic nephropathy , blood pressure , diabetes mellitus

The aim of the study was to investigate the antihypertensive effects of angiotensin II type-1 receptor blocker, losartan, and its potential in slowing down renal disease progression in spontaneously hypertensive rats (SHR) with adriamycin (ADR) nephropathy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research